Clinical Study
Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
Table 2
Major outcomes of RAK and BRAK for Helicobacter pylori eradication.
| ||||||||||||||||||||||||||||||||||||
7 patients had an unknown H. pylori status after treatment (3 in RAK group, 4 in RBAK group). |